<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對照品 > 標(biāo)準(zhǔn)物質(zhì) > 鐵標(biāo)準(zhǔn)物質(zhì) >
    Tri-O-formylcholic Acid
    產(chǎn)品基本信息
    產(chǎn)品編號:T793660
    產(chǎn)品名稱:Tri-O-formylcholic Acid
    產(chǎn)品CAS:2097-89-4
    規(guī)格含量:1g
    產(chǎn)品價格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號: T793660
    名稱: Tri-O-formylcholic Acid
    別名: (3α,5β,7α,12α)-3,7,12-Tris(formyloxy)-cholan-24-oic Acid; Cholic Acid Triformate;
    CAS號: 2097-89-4
    分子式: C??H??O?
    分子量: 492.6
    類別: Building Blocks; Steroids;
    應(yīng)用: Tri-O-formylcholic Acid is an intermediate used in the synthesis of 3α,7α,12α-Trihydroxycoprostanic Acid-d3 (T795157), which is a labelled analogue of 3α,7α,12α-Trihydroxycoprostanic Acid (T795155), a precursor of Cholic Acid (C432600), it undergoes side chain oxidation during the synthesis of bile acids. It was found that Zellweger’s syndrome patients have abnormal mitochondrial structure, the organelle that is responsible for the side chain oxidation, and as a consequence, excess amounts of 3α,7α,12α-Trihydroxycoprostanic Acid.
    參考文獻(xiàn)


    2011-2018 信陽萊耀生物科技有限公司 版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      国产三级精品三级 | 青娱乐亚洲日韩 | 男女操逼视频免费看 | 国产尤物av尤物在线看 | 国产探花福利福利私拍av在线 |